Skip to main content

Clinical Effects of Partial Correction of Anemia Using Recombinant Human Erythropoietin on Working Capacity in Dialysis Patients

  • Conference paper
Erythropoietin
  • 103 Accesses

Abstract

Modern dialysis treatment for terminal renal failure enables long-term survival in a majority of patients. In the wake of the early reports of Winearls and Eschbach [1, 2] on the effectiveness of recombinant human erythropoietin (r-HuEpo) in the treatment of renal anemia in patients on chronic hemodialysis, the widespread use of this exciting treatment can be expected shortly. However, because of the high treatment costs, attention is beginning to be focused on the impact that partial correction of anemia will have on dialysis therapy in general. The major issue is certainly the potential improvement of quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Winearls CG, Oliver DO, Pippard MJ, Reid C, Downing MR, Cotes PM (1986) Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet II: 1175–1177

    Article  Google Scholar 

  2. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW (1987) Correction of the anaemia of end stage renal disease with recombinant human erythropoietin. N Engl J Med 316: 73–78

    Article  PubMed  CAS  Google Scholar 

  3. Evans RW, Manninen DL, Garrison LP, Hart LG, Blagg CR, Gutman RA, Hull AR, Lowrie EG (1985) The quality of life of patients with end stage renal disease. N Engl J Med 312: 553–559

    Article  PubMed  CAS  Google Scholar 

  4. Brynger H, Brunner FP, Chantier C, Doncker Wolke RA, Jakobs C, Kramer P, Selwood NH, Wing AJ (1980) Combined report on regular dialysis and transplantation in Europe. Proc Eur Dial Transpl Assoc 17: 3–10

    Google Scholar 

  5. Goldberg AP, Geltman EM, Hagberg JM, Gavin JR, Delmez ME, Carney RM, Naumowicz A, Oldfield M, Harter H (1983) The therapeutic benefits of exercise training for haemodialysis patients. Kidney Int 16: s303–s309

    CAS  Google Scholar 

  6. Carney RM, Templeton B, Hong BA, Harter HR, Hagberg JM, Schechtman KB, Goldberg Ap (1987) Exercise training reduces depression and increases the performance of pleasant activities in haemodialysis patients. Nephron 47: 194–198

    Article  PubMed  CAS  Google Scholar 

  7. Wassermann K, Whipp BS, Koyal SN, Beaver WL (1973) Anaerobic threshold and respiratory gas exchange during exercise. J Appl Physiol 35: 236–243

    Google Scholar 

  8. Wassermann K (1984) The anaerobic threshold measurement to evalute exercise performance. Am Rev Respir Dis [Suppl] 129: 535–540

    Google Scholar 

  9. Kumagai S, Tanaka K, Matsura Y, Matzuzaka A, Hirakoba K, Asano K (1982) Relationship of the anaerobic threshold with the 5 km, 10 km and 10 miles races. Eur J Appl Physiol 49: 13–23

    Article  CAS  Google Scholar 

  10. Löllgen H (1986) Kardiopulmonale Funktionsdiagnostik, 4th edn. Edition Ciba

    Google Scholar 

  11. Lichtman M, Miller DR (1970) Erythrocyte glycolysis, 2,3-diphosphoglycerate and adenosine triphosphate concentration in uremic subjects: relationship to extracellular phosphate concentration. J Lab Clin Med 76: 267–279

    PubMed  CAS  Google Scholar 

  12. Mayer G, Thum J, Graf H (1989) Anaemia and reduced exercise capacity in patients on chronic haemodialysis. Clin Sci 76: 265–268

    PubMed  CAS  Google Scholar 

  13. Neff MS, Kim KE, Persoff M, Onesti G, Swartz C (1971) Hemodynamics in anaemic patients. Circulation 18: 876–883

    Google Scholar 

  14. Mayer G, Steffenelli TH, Thum J, Cada EM, Stummvoll HK, Graf H (1988) Haemodynamic parameters and blood viscosity in the pathogenesis of erythropoietin treatment related hypertension. Nephrol Dial Transpl (abstr) 3: 499

    Google Scholar 

  15. Painter P, Messer-Rehak D, Hanson P, Zimmermann SW, Glass NR (1986) Exercise capacity in haemodialysis, CAPD, and renal transplant recipients. Nephron 42: 47–51

    Article  PubMed  CAS  Google Scholar 

  16. Graf H, Mayer G, Cada EM, Thum J, Stummvoll HK (1987) Wirksamkeit von rekombinantem humanem Erythropoietin in der Behandlung der transfusionsabhängigen Anämie chronischer Dialysepatienten. Wien Klin Wochenschr 24: 855–859

    Google Scholar 

  17. Jones NL (1984) Evaluation of a microprocessor controlled exercise testing system. J Appl Physiol 57: 1312–1318

    PubMed  CAS  Google Scholar 

  18. Graf H, Irschik H, Kovarik J, Stummvoll HK (1986) A new algorithm for individual dialysis prescription. Med Prog Technol 11: 191–196

    PubMed  CAS  Google Scholar 

  19. Mayer G, Thum J, Cada EM, Graf H (1988) Working capacity is increased following r-HuEpo treatment. Kidney Int 34: 525–528

    Article  PubMed  CAS  Google Scholar 

  20. Mayer G, Thum J, Cada EM, Stummvoll HK, Graf H (1988) Verhalten der aeroben und anaeroben Leistungsfähigkeit chronischer Haemodialyse Patienten unter einer Dauertherapie mit rekombinantem humanem Erythropoietin. Nephron 51 (Suppl): 34–38

    Article  Google Scholar 

  21. Mayer G, Stefenelli T, Cada EM, Thum J, Stummvoll HK, Graf H (1988) Blood pressure and erythropoietin. Lancet I: 351–352

    Google Scholar 

  22. Cropp GJA (1969) Hemodynamic responses to oxygen breathing in children with severe anemia. Circulation 15: 493–500

    Google Scholar 

  23. Chester AC, Argy WP, Rakowski TA, Schreiner GE (1978) Polycystic kidney disease and chronic haemodialysis. Clin Nephrol 10: 129

    PubMed  CAS  Google Scholar 

  24. Brenner BM, Rector FC (eds) (1986) The kidney. Saunders, Philadelphia

    Google Scholar 

  25. West JB (1986) Lactate during exercise at extreme altitude. Fed Proc 45: 2953–2957

    PubMed  CAS  Google Scholar 

  26. Young AS, Evens WS, Fisher EC, Sharp RL, Costill DL, Maher JT (1984) Skeletal muscle metabolism of sea level natives following short term high altitude residence. Eur J Appl Physiol 52: 463–466

    Article  CAS  Google Scholar 

  27. Metcoff J, Lindeman R, Baxter D, Pederson J (1978) Cellular metabolism in uremia. Am J Clin Nutr 30: 1627–1637

    Google Scholar 

  28. Nakad T, Fujiwara S, Isoda K, Miyahara T (1982) Impaired lactate production by skeletal muscle with anaerobic exercise in patients with chronic renal failure. Nephron 31: 111–115

    Article  Google Scholar 

  29. Graf H, Koniecna T, Sachs E, Cada EM, Mayer G (1988) Psychological effects of correction of anemia by recombinant human erythropoietin in patients on chronic hemodialysis. Clin Res 36: 519A

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Graf, H., Mayer, G. (1989). Clinical Effects of Partial Correction of Anemia Using Recombinant Human Erythropoietin on Working Capacity in Dialysis Patients. In: Jelkmann, W., Gross, A.J. (eds) Erythropoietin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83745-6_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-83745-6_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-83747-0

  • Online ISBN: 978-3-642-83745-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics